drugset / Trial / NCT00631137
Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma
Terminated
1 enrolled
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI) · collab
RandomizedParallel-groupTriple-blindSupportive care
Summary
RATIONALE: Testosterone gel may be effective in preventing or lessening muscle weakness caused by steroid therapy in men receiving glucocorticoids for newly diagnosed high-grade glioma. PURPOSE: This randomized clinical trial is studying how well testosterone gel works in preventing weakness caused by steroid therapy in men receiving glucocorticoids for newly diagnosed high-grade glioma.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-09
- Completion
- 2008-09
Outcome
Outcome not reported
Stopped (Enrollment): “Study terminated due to low accrual.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | testosterone gel | Unknown | 10 g | Topical |